MedPath

Individual Approach for Bowel Preparation Before Colonoscopy

Not Applicable
Completed
Conditions
Risk Factors Inadequate Preparation
Split-dose Bowel Preparation
Polyethylene Glycol Solution
Interventions
Other: individual preparation for colonoscopy
Registration Number
NCT01476735
Lead Sponsor
Maria Sklodowska-Curie National Research Institute of Oncology
Brief Summary

This is a prospective, randomized, single-blind study designed to evaluate the influence of individual approach on bowel preparation quality for colonoscopy. The investigators compare split-dose polyethylene glycol solution (PEG, Fortrans, Beaufour Ipsen) to modified split-dose PEG regarding predictors of inadequate preparation for colonoscopy.

Detailed Description

Up to 22% of patients are not good prepared for colonoscopy and it is caused of aborted procedures and increased costs. There are identified predictors of inadequate bowel preparation before colonoscopy, but we still don't know if an individual approach improve the quality of preparation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
266
Inclusion Criteria
  • men and women more than 18 years of age undergoing colonoscopy for routine clinical indications
  • provided written informed consent
Exclusion Criteria
  • lack of written informed consent or inability to provide informed consent or refusal to consent to the study
  • pregnancy and breast feeding
  • known allergy to PEG or bisakodyl
  • presence of serious conditions such as severe cadiac, renal or metabolic diseases, major psychiatric illness or end-stage cancer disease requiring taking narcotic drugs
  • colonoscopy performed under conscious sedation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
split-dose polyethylene glycol solutionindividual preparation for colonoscopyfirst dose (1,5 l) of polyethylene glycol solution taken at 6-7.00 in the evening before colonoscopy, second dose (1,5 l) taken at 5.30-6.00 in the morning of a day of colonoscopy; additional bisacodyl taken at 12.00 at the day before colonoscopy
Individual preparation for colonoscopyindividual preparation for colonoscopy-
Primary Outcome Measures
NameTimeMethod
the index of preparation quality for the whole colon24 hours

the percentage of patients with adequate bowel preparation; adequate preparation is defined as excellent, good and fair, inadequate is defined as poor or unprepared colon according to the Ottawa bowel preparation scale

Secondary Outcome Measures
NameTimeMethod
compliance safety24 hours

number of patients with completion of preparation number of patients with side effects of preparation in each group

Trial Locations

Locations (1)

Maria Sklodowska-Curie Memorial cancer Center, Institute of Oncology

🇵🇱

Warsaw, Poland

© Copyright 2025. All Rights Reserved by MedPath